Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Nov 28;25(18):2295-9.
doi: 10.1097/QAD.0b013e32834c4c22.

Modeling the impact on the HIV epidemic of treating discordant couples with antiretrovirals to prevent transmission

Affiliations

Modeling the impact on the HIV epidemic of treating discordant couples with antiretrovirals to prevent transmission

Wafaa M El-Sadr et al. AIDS. .

Abstract

Background: The HPTN 052 study demonstrated a 96% reduction in HIV transmission in discordant couples using antiretroviral therapy (ART).

Objective: To predict the epidemic impact of treating HIV-discordant couples to prevent transmission.

Design: Mathematical modeling to predict incidence reduction and the number of infections prevented.

Methods: Demographic and epidemiological data from Ghana, Lesotho, Malawi and Rwanda were used to parameterize the model. ART was assumed to be 96% effective in preventing transmission.

Results: Our results show there would be a fairly large reduction in incidence and a substantial number of infections prevented in Malawi. However, in Ghana a large number of infections would be prevented, but only a small reduction in incidence. Notably, the predicted number of infections prevented would be similar (and low) in Lesotho and Rwanda, but incidence reduction would be substantially greater in Lesotho than Rwanda. The higher the proportion of the population in stable partnerships (whether concordant or discordant), the greater the effect of a discordant couple's intervention on HIV epidemics.

Conclusion: The effectiveness of a discordant couples intervention in reducing incidence will vary among countries due to differences in HIV prevalence and the percentage of couples that are discordant (i.e. degree of discordancy). The number of infections prevented within a country, as a result of an intervention, will depend upon a complex interaction among three factors: population size, HIV prevalence and degree of discordancy. Our model provides a quantitative framework for identifying countries most likely to benefit from treating discordant couples to prevent transmission.

PubMed Disclaimer

Figures

Figure 1
Figure 1. The impact of treating discordant couples to prevent transmission as a function of treatment coverage
Treatment coverage (i.e., the percentage of discordant couples that receive antiretroviral therapy) ranges from 0 to 100%. Results are shown for Lesotho (black), Malawi (red), Rwanda (blue), and Ghana (green). The effect of treatment coverage on the annual incidence rate (per 1000 person-years) (a) and (b) and on the annual number of infections prevented (c) and (d). Calculations shown in (a) and (c) are based on the assumption that 40% of the population is in stable partnerships; stable partnerships include concordant positive, concordant negative and discordant couples. Calculations shown in (b) and (d) are based on the assumption that 70% of the population is in stable partnerships.

Similar articles

Cited by

References

    1. UNAIDS Global Report 2010 http://www.unaids.org/globalreport/documents/20101123_GlobalReport_full_.... [Accessed 15 June 2011]
    1. Siegfried N, Muller M, Deeks JJ, Volmink J. Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev. 2009;(2):CD003362. - PMC - PubMed
    1. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168–1174. Epub 2010 Jul 19. - PMC - PubMed
    1. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. Lancet. 2009;373:48–57. - PubMed
    1. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N. Prevention of HIV-1 Infection with Early Antiretroviral Therapy. N Engl J Med. 2011;365:493–505. - PMC - PubMed

Publication types

Substances